Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 17
- +1 vs. Q3 2022
- Portfolio value
- $39.1M
- −$2.71M (−6.5%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LANWFLanvin Group Holdings Ltd | *W EXP 99/99/999 | 12,000 | $3.78K | <0.1% | +12,000 | New | History |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 39,773 | $4.67K | <0.1% | 00.0% | Unchanged | – |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 21,333 | $17.8K | <0.1% | +21,333 | New | History |
| ELEVElevation Acquisition Group Inc. | COM | 68,324 | $64.8K | 0.2% | +270.0% | Added | History |
| ALLKAllakos Inc. | COM | 18,271 | $153.8K | 0.4% | +18,271 | New | History |
| MTEMMolecular Templates, Inc. | COM | 2,052,991 | $673.4K | 1.7% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 84,728 | $783.7K | 2.0% | +84,728 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 211,159 | $1.06M | 2.7% | +211,159 | New | History |
| Alps ETF Tr00162Q452 | ALERIAN MLP | 29,500 | $1.12M | 2.9% | 00.0% | Unchanged | – |
| ACLXArcellx, Inc. | COMMON STOCK | 36,302 | $1.12M | 2.9% | −39,884−52.4% | Reduced | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 156,222 | $1.35M | 3.4% | +15,359+10.9% | Added | – |
| SPDR Series Trust78468R556 | SP O&G EXPL PRO | 17,500 | $2.38M | 6.1% | 00.0% | Unchanged | – |
| SCYXScynexis Inc | COM NEW | 1,723,947 | $2.69M | 6.9% | 00.0% | Unchanged | History |
| RZLTRezolute, Inc. | COM NEW | 1,403,157 | $2.90M | 7.4% | 00.0% | Unchanged | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 15,947 | $6.10M | 15.6% | 00.0% | Unchanged | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 6,039,028 | $8.03M | 20.5% | 00.0% | Unchanged | History |
| SVRASavara Inc | COM | 6,896,551 | $10.7M | 27.3% | 00.0% | Unchanged | History |
Sold out since Q3 2022 (4)
Positions held at the end of Q3 2022 that are gone from this filing.
| Security | Class | Shares in Q3 2022 | Value in Q3 2022 | % of portfolio in Q3 2022 | History |
|---|---|---|---|---|---|
| EIGREiger BioPharmaceuticals, Inc. | COM | 116,884 | $880.0K | 2.1% | History |
| Frazier Lifesciences Acqu CoG3710A113 | *W EXP 11/30/202 | 21,333 | $17.0K | <0.1% | – |
| Lux Health Tech Acquisition55068A118 | *W EXP 11/30/202 | 66,666 | $9.00K | <0.1% | – |
| Primavera Capital Acquist CoG7255E117 | *W EXP 01/19/202 | 12,000 | $2.00K | <0.1% | – |